InvestorsObserver
×
News Home

Does Altimmune Inc (ALT) Have What it Takes to be in Your Portfolio Wednesday?

Wednesday, October 13, 2021 10:48 AM | InvestorsObserver Analysts

Mentioned in this article

Does Altimmune Inc (ALT) Have What it Takes to be in Your Portfolio Wednesday?

Altimmune Inc (ALT) is near the top in its industry group according to InvestorsObserver. ALT gets an overall rating of 55. That means it scores higher than 55 percent of stocks. Altimmune Inc gets a 81 rank in the Biotechnology industry. Biotechnology is number 83 out of 148 industries.

Overall Score - 55
ALT has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on ALT!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 55 would rank higher than 55 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Altimmune Inc Stock Today?

Altimmune Inc (ALT) stock is up 0.16% while the S&P 500 has fallen -0.1% as of 10:40 AM on Wednesday, Oct 13. ALT has risen $0.02 from the previous closing price of $12.41 on volume of 175,840 shares. Over the past year the S&P 500 has gained 23.76% while ALT has fallen -12.59%. ALT lost -$1.81 per share the over the last 12 months. Click Here to get the full Stock Report for Altimmune Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App